Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis

Nature Genetics
Kaarina KowalecBruce C Carleton

Abstract

Multiple sclerosis (MS) is a disease of the central nervous system treated with disease-modifying therapies, including the biologic, interferon-β (IFN-β). Up to 60% of IFN-β-exposed MS patients develop abnormal biochemical liver test results1,2, and 1 in 50 experiences drug-induced liver injury3. Since genomic variation contributes to other forms of drug-induced liver injury4,5, we aimed to identify biomarkers of IFN-β-induced liver injury using a two-stage genome-wide association study. The rs2205986 variant, previously linked to differential expression of IRF6, surpassed genome-wide significance in the combined two-stage analysis (P = 2.3 × 10-8, odds ratio = 8.3, 95% confidence interval = 3.6-19.2). Analysis of an independent cohort of IFN-β-treated MS patients identified via electronic medical records showed that rs2205986 was also associated with increased peak levels of aspartate aminotransferase (P = 7.6 × 10-5) and alkaline phosphatase (P = 4.9 × 10-4). We show that these findings may be applicable to predicting IFN-β-induced liver injury, offering insight into its safer use.

References

Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Dec 18, 2002·Annals of Internal Medicine·George OstapowiczUNKNOWN U.S. Acute Liver Failure Study Group
Aug 12, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Gordon S FrancisNeil Kaplowitz
Feb 17, 2006·The New England Journal of Medicine·Victor J Navarro, John R Senior
Aug 26, 2006·Nature Reviews. Immunology·Kenya Honda, Tadatsugu Taniguchi
May 27, 2008·Clinical Pharmacology and Therapeutics·D M RodenD R Masys
Jul 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Isabel LucenaUNKNOWN Spanish Group for the Study of Drug-Induced Liver Disease
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robert J FontanaUNKNOWN DILIN Study Group
May 29, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Isabel LucenaUNKNOWN Spanish Group for the Study of Drug-Induced Liver Disease
Jun 2, 2009·Nature Genetics·Ann K DalyUNKNOWN International SAE Consortium
Nov 26, 2009·Autoimmunity Reviews·Ron Milo, Esther Kahana
Jul 17, 2010·Bioinformatics·Randall J PruimCristen J Willer
Jul 20, 2010·Nature Genetics·Jonathan B SingerCharles A Paulding
Dec 15, 2010·Multiple Sclerosis : Clinical and Laboratory Research·S ChanH Tremlett
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Colin F SpraggsLon R Cardon
Mar 10, 2011·Annals of Neurology·Chris H PolmanJerry S Wolinsky
Mar 19, 2011·BMC Bioinformatics·Xavier RobinMarkus Müller
Mar 25, 2011·The New England Journal of Medicine·Pei ChenUNKNOWN Taiwan SJS Consortium
May 6, 2011·Clinical Pharmacology and Therapeutics·G P AithalA K Daly
Aug 13, 2011·Nature·UNKNOWN International Multiple Sclerosis Genetics ConsortiumAlastair Compston
Feb 5, 2013·Digestive Diseases and Sciences·Robert J FontanaMarwan Ghabril
Jun 14, 2013·PloS One·Xiaoming JiaPaul I W de Bakker
Oct 24, 2013·Journal of the American Medical Informatics Association : JAMIA·Mary F DavisJonathan L Haines
Aug 20, 2014·Expert Opinion on Drug Safety·Kaarina KowalecHelen Tremlett
Aug 26, 2014·Journal of Hepatology·Pi-Xiao WangHongliang Li
Oct 17, 2014·Nature Protocols·Yan GuoJirong Long
Nov 14, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Sergio E BaranziniBruce Ac Cree
Feb 28, 2015·GigaScience·Christopher C ChangJames J Lee
Oct 4, 2015·Nature·UNKNOWN 1000 Genomes Project ConsortiumGonçalo R Abecasis

❮ Previous
Next ❯

Citations

Aug 7, 2018·Expert Review of Molecular Diagnostics·Mitchell R McGill, Hartmut Jaeschke
Nov 20, 2018·Journal of Clinical Pharmacology·Reo TanoshimaUNKNOWN Canadian Pharmacogenomics Network for Drug Safety Consortium
Oct 27, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Georgios M HadjigeorgiouEfthimios Dardiotis
Jan 21, 2019·Clinical Pharmacology and Therapeutics·Paola NicolettiUNKNOWN International Drug-Induced Liver Injury Consortium (iDILIC)
Oct 22, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mark RealJames H Lewis
Aug 24, 2019·Nature Reviews. Disease Primers·Raul J AndradeGuruprasad P Aithal
Jul 19, 2020·British Journal of Pharmacology·Sophie L PenmanAmy E Chadwick
Aug 31, 2020·NPJ Genomic Medicine·Takuto TakahashiPamala A Jacobson
Jun 15, 2019·Expert Review of Neurotherapeutics·Xavier AyrignacPierre Duquette
Aug 4, 2020·Expert Opinion on Drug Safety·Dejan JakimovskiBianca Weinstock-Guttman
Oct 30, 2020·Pharmacogenomics and Personalized Medicine·Concetta CafieroSalvatore Pisconti
Nov 24, 2020·Expert Opinion on Drug Metabolism & Toxicology·Camilla StephensRaúl J Andrade
Feb 13, 2021·NPJ Genomic Medicine·Takuto TakahashiPamala A Jacobson
Apr 7, 2021·Drug Metabolism Reviews·Laura E RussellVolker M Lauschke
May 22, 2021·Pharmacological Reviews·Samantha Christine SernoskieJack Paul Uetrecht

❮ Previous
Next ❯

Datasets Mentioned

BETA
EGAD00000000120

Methods Mentioned

BETA
genotyping

Software Mentioned

IMPUTE2
TaqMan Genotyper
QCTOOL
LocusZoom
PLINK
SNPTEST
R for Statistical Computing
SHAPEIT
SPSS
Genotype Harmonizer

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.